1.Heywood, AE, et al. Elimination of endemic measles transmission in Australia. Bulletin of the World Health Organisation 2009; 87: 64–71.
2.Communicable Diseases Network Australia and New Zealand. Revised guidelines for the follow up of communicable diseases reported among travellers on aeroplanes. Canberra: CDNA, 2006.
3.Centres for Disease Control and Prevention. Interstate importation of measles following transmission in an airport – California, Washington, 1982. Morbidity & Mortality Weekly Report 1983; 32: 210–215.
4.Amler, R, et al. Imported measles in the United States. Journal of the American Medical Association 1982; 248: 2129–2133.
5.Mangili, A, Gendreau, M. Transmission of infectious diseases during commercial air travel. Lancet 2005; 365: 989–996.
6.Dayan, GH, et al. The cost of containing one case of measles: the economic impact on the public health infrastructure – Iowa, 2004. Pediatrics 2005; 116: e1–4.
7.de Barros, F, et al. Measles transmission during commercial air travel in Brazil. Journal of Clinical Virology 2006; 36: 235–236.
8.Pauli, N, et al. Low risk of measles transmission after exposure on an international an airline flight. Journal of Infectious Diseases 2004; 189 (Suppl. 1): 81–85.
9.National Health and Medical Research Council. The Australian Immunisation Handbook, 9th edn. Canberra: Department of Health and Ageing, 2008.
10.Hamkar, R, et al. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay. Eastern Mediterranean Health Journal 2006; 12: 775–782.
11.Atrasheuskaya, AV, et al. Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000–2005. Vaccine 2008; 26: 2111–2118.
12.Ishiwada, N, et al. Vaccine-modified measles in previously immunized children in Accra, Ghana: clinical, virological and serological parameters. Tropical Medicine & International Health 2001; 6: 694–698.
14.Tropical Public Health Unit. A measles outbreak in far north Queensland. CDC Newsletter 2008; 58: 1–3.
15.Riddell, MA, Rota, JS, Rota, PA. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras. Virology Journal 2005; 2: 87–96.
16.Paunio, M, et al. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiology and Infection 2000; 124: 263–271.
17.Edmonson, MB, et al. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. Journal of the American Medical Association 1990; 263: 2467–2471.
18.Tan, PL, et al. Twin studies of immunogenicity – determining the genetic contribution to vaccine failure. Vaccine 2001; 19: 2434–2439.
19.Centre for Disease Control.Northern Territory Disease Control Bulletin 2008; 15: 34.